NORD Issues Statement on FDA’s New Associate Director for Rare Diseases
The following statement was issued by Peter L. Saltonstall, President and CEO of the National Organization for Rare Disorders (NORD), on today’s announcement that Jonathan C. Goldsmith, MD, FACP, will …
Continue reading “NORD Issues Statement on FDA’s New Associate Director for Rare Diseases”
Read more